OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Application of Novel Degraders Employing Autophagy for Expediting Medicinal Research
Xiang Li, Qian Liu, Xin Xie, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 3, pp. 1700-1711
Closed Access | Times Cited: 23

Showing 23 citing articles:

Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xin Xie, Tingting Yu, Xiang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 151

Expanding the horizons of targeted protein degradation: A non-small molecule perspective
Xiaowei Huang, Fengbo Wu, Jing Ye, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2402-2427
Open Access | Times Cited: 16

Targeting Tau Protein with Proximity Inducing Modulators: A New Frontier to Combat Tauopathies
Elisa Uliassi, María Laura Bolognesi, Andrea Milelli
ACS Pharmacology & Translational Science (2025) Vol. 8, Iss. 3, pp. 654-672
Closed Access | Times Cited: 2

Heat shock proteins as hallmarks of cancer: insights from molecular mechanisms to therapeutic strategies
Wei‐Fang Zuo, Qiwen Pang, Xinyu Zhu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 9

Targeted protein degradation in drug development: Recent advances and future challenges
Jian H. Song, Mingzheng Hu, Jun Zhou, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115839-115839
Closed Access | Times Cited: 17

Exploration of Degrons and Their Ability to Mediate Targeted Protein Degradation
Timothy J. Harris, Darci J. Trader
RSC Medicinal Chemistry (2025)
Closed Access

Harnessing Natural Saponins: Advancements in Mitochondrial Dysfunction and Therapeutic Applications
Hongmei Liu, Huan Wang, Xinyu Lin, et al.
Phytomedicine (2025) Vol. 138, pp. 156383-156383
Closed Access

Targeted Protein Degradation in Cancer Therapy via Hydrophobic Polymer-Tagged Nanoparticles
Seohee Lee, Seonwoo Kang, Won Jong Kim
ACS Nano (2025)
Closed Access

Mechanisms and Therapeutic Strategies for NLRP3 Degradation via Post-Translational Modifications in Ubiquitin-proteasome and Autophagy Lysosomal Pathway
Kaiyue Su, Minghai Tang, Jie Wu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117476-117476
Closed Access

Metal-free assembly of diverse polysubstituted pyridines via an efficient cascade approach using tertiary enaminones and α,β-unsaturated sulfonylketimines
Xiang Li, Qiwen Pang, Yang Zhang, et al.
Organic Chemistry Frontiers (2024) Vol. 11, Iss. 9, pp. 2607-2612
Closed Access | Times Cited: 4

Autophagy modulation in cancer therapy: Challenges coexist with opportunities
Yongya Wu, Aoxue Wang, Guotai Feng, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116688-116688
Closed Access | Times Cited: 3

Lighting the way to diverse cyclic architectures: expanding the horizons with photogenerated ketenes in sustainable chemistry
Wei‐Fang Zuo, Qian Liu, Xin Xie, et al.
Organic Chemistry Frontiers (2023) Vol. 10, Iss. 18, pp. 4474-4487
Open Access | Times Cited: 8

Design, synthesis, and biological evaluation of novel discoidin domain receptor inhibitors for the treatment of lung adenocarcinoma and pulmonary fibrosis
Shangke Liu, Xiang Li, Can Chen, et al.
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116100-116100
Closed Access | Times Cited: 5

Discovery of autophagy-tethering compounds as potent NLRP3 degraders for IBD Immunotherapy
Kai Yin, Ziwen Zhang, Yanqing Mo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116581-116581
Closed Access | Times Cited: 1

Targeted Strategies for Degradation of Key Transmembrane Proteins in Cancer
Vehary Sakanyan, Nina Iradyan, Rodolphe Alves de Sousa
BioTech (2023) Vol. 12, Iss. 3, pp. 57-57
Open Access | Times Cited: 3

Assembly of spirocyclic pyrazolone-pyrrolo[4,3,2-de]quinoline skeleton via cascade [1,5] hydride transfer/cyclization by C(sp3)–H functionalization
Xin Xie, He Huang, Yu Fan, et al.
Organic & Biomolecular Chemistry (2023) Vol. 21, Iss. 36, pp. 7300-7304
Closed Access | Times Cited: 2

PROTAC<sup>®</sup> technology and potential for its application in infection control
M. A. Zakharova, М. В. Чудинов
Fine Chemical Technologies (2024) Vol. 19, Iss. 3, pp. 214-231
Open Access

Targeted protein degradation in the mitochondrial matrix and its application to chemical control of mitochondrial morphology
Wakana Yamada, Shusuke Tomoshige, Sho Nakamura, et al.
Chemical Science (2024) Vol. 15, Iss. 36, pp. 14625-14634
Open Access

[3+2] Cycloaddition of Rationally Designed Trisubstituted Cyclic α‐Chloroamide: an Alternative Strategy for Accessing Spirocyclic γ‐Lactam Architecture
Yang Li, Wei‐Fang Zuo, Jianhua Chen, et al.
Advanced Synthesis & Catalysis (2023) Vol. 366, Iss. 2, pp. 269-276
Closed Access | Times Cited: 1

Machine learning approaches for the identification of ligands of the autophagy marker LC3
Laurent Soulère, Yves Queneau
Artificial Intelligence Chemistry (2023) Vol. 1, Iss. 2, pp. 100022-100022
Open Access

Targeted Protein Degraders- The Druggability Perspective
Satinder Singh, Pratima Srivastava
Journal of Pharmaceutical Sciences (2023) Vol. 113, Iss. 3, pp. 539-554
Closed Access

Page 1

Scroll to top